Facebook Follow AMS on Linkedin Follow us on Twitter @amsmenopausen AMS on Instagram
  • AMS: MenopauseDown Under

    AMS: Menopause
    Down Under

    Recording now available online

    Read more

  • A Practitioner’s Toolkitfor Managing Menopause

    A Practitioner’s Toolkit
    for Managing Menopause

    Providing clear, evidence-based advice

    Read more

  • AMS eLearning

    AMS eLearning

    A benefit for AMS Members
    webinars, case studies
    with CPD points

    Read more

  • Health Information

    Health Information

    Find an AMS Doctor, news,
    self-assessment tools and videos

    Read more

  • Menopause management

    Menopause management

    AMS supporting women through
    midlife health and the menopause

    Read more

About AMS

About AMS

About AMS >>>

AMS Members

AMS Members
AMS Members >>>

Health Professionals

Health professionals

Health Professionals >>>

Consumer Information

Consumers

Women's health information >>>

Workplaces

Workplaces

Workplaces >>>

Menopausal Hormone Therapy (MHT) patch shortages May 2024

Australia 

There are a number of patches that are currently unavailable. Please note that the TGA has approved some unregistered products for supply under Section 19A.

Oestradiol patches

 

Expected supply due

Alternative supply under Section 19A

Dose

Estradot

Estraderm

Estramon

Estradiol Transdermal System

25 mcg

15 Jun 2024

Available

Available

 

37.5 mcg

15 Jul 2024

 

Available

Available

50 mcg

15 Jun 2024

Low availability

Available

 

75 mcg

15 Jun 2024

Available

Available

Available

100 mcg

15 Jul 2024

Available

Available

Available

Combined patches

Dose

Estalis Sequi

Estalis Conti

50/140

Low availability

3 May2024

50/250

Low availability

Available

All doses of Climara have been deleted from the market and there will be a reduction in supply until supply is exhausted.

The AMS Guide to MHT Doses (Australia only) provides a guideline to approximately equivalent doses of the different MHT/HRT products in Australia.

Continue Reading

About the AMS

Members of the Australasian Menopause Society Limited (AMS) are doctors and other health care professionals who each have a special interest in women's health in midlife and menopause and the promotion of healthy ageing. 

Whether information is needed about peri-menopause, MHT/HRT and alternatives, osteoporosis or how to locate a doctor interested in women's health, the AMS seeks to bring accurate, evidence-based information to health care workers and the wider community.

Continue Reading

Gender Language Policy

The Australasian Menopause Society acknowledges that some individuals who undergo menopause do not identify as women. We are committed to inclusion and respect for our members, the patients we treat and the wider community.

Gender Language Policy
The Australasian Menopause Society (AMS) recognises gender diversity. In our publications, presentations, printed and digital materials, AMS uses the word “woman” (and the pronouns “she” and “her”) to refer to all individuals in the context of discussion of menopause. When describing or referencing study populations used in research, AMS will use the gender terminology reported by the study investigators.

Continue Reading

What's New on AMS

AMS Features

 

Search

Facebook Follow AMS on Linkedin Follow us on Twitter @amsmenopauseAMS on Instagram